Zhuzhou Qianjin Pharmaceutical Co., Ltd.SSE: 600479

(600479)"Zhuzhou Qianjin Pharmaceutical Co., Ltd."Announcement on Listing and Trading of Certain Restricted Shares in Respect of the Share Issuance and Cash Payment for Asset Acquisition and Related Party Transactions

· Issued by Zhuzhou Qianjin Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600479 · · 4 pages · Chinese

Summary by 6ix AI

Zhuzhou Qianjin Pharmaceutical Co., Ltd. announced the listing and trading of certain restricted shares related to an asset acquisition and related party transactions. The announcement details the issuance of shares and cash payment for asset acquisition, with specific information on the number of shares and their lock-up periods. The total number of restricted shares being listed is significant, and the trading date is specified. The filing includes commitments from shareholders regarding the transfer of shares and confirms compliance with relevant regulations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600479zhuzhou-qianjin-pharmaceutical-co-ltdannouncement-on-listing-and-trading-of-certain-restricted-shares-in-respect-of-the-share-issuance-and-cash-payment-for-asset-acquisition-and-related-party-transactions

Release

The total number of shares to be listed and traded is 19,958,905 shares, and the listing and trading date is October 23, 2026.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Zhuzhou Qianjin Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhuzhou Qianjin Pharmaceutical

Later from Zhuzhou Qianjin Pharmaceutical

All Zhuzhou Qianjin Pharmaceutical news releases